Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis
Verdict: WATCH (do not buy)
Strong organic growth and deleveraging support low P/E valuation, but private equity sponsor sell-downs create heavy supply overhang.
Investment score: 58/100
Analysis as of
Is Aveanna Healthcare Holdings Inc stock worth reviewing? The TradeMates thesis
Aveanna demonstrates operational improvement and earnings momentum, but its debt load and sponsor share sales dictate a cautious approach.
7-factor investment score
- Valuation: 65/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 15/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Aveanna Healthcare Holdings Inc opportunities and risks
What speaks for AVAH
- Sustained earnings outperformance driven by preferred-payer rate increases and volume growth
What speaks against AVAH
- Sponsor sell-down supply overhang restricting stock upside
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| AVAH | 10.0x | 1.1x | 14.0x | 32.0% | 10.6% | 5.7% |
| LFST | 96.5x | 3.0x | 36.3x | 33.6% | 3.2% | 4.4% |
| OPCH | 23.5x | 0.8x | 13.9x | 18.2% | 3.7% | 7.4% |
| CRVL | 37.3x | 4.3x | 21.8x | 23.9% | 11.7% | 2.7% |
| PRVA | 101.8x | 1.2x | n/a | 7.6% | 1.2% | -1.7% |
| GRDN | 37.7x | 1.7x | 20.5x | 21.6% | 4.5% | 3.2% |
| Peer median | 37.7x | 1.7x | 20.5x | 21.6% | 3.7% | 3.2% |
Frequently asked questions about Aveanna Healthcare Holdings Inc (AVAH)
Is AVAH stock a good investment?
The TradeMates model rates Aveanna Healthcare Holdings Inc as WATCH (do not buy) with an investment score of 58/100. Aveanna demonstrates operational improvement and earnings momentum, but its debt load and sponsor share sales dictate a cautious approach. This is algorithmic model output, not personal investment advice.
Is AVAH stock a buy?
The TradeMates model verdict for AVAH is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.